Bile Acid Lithocholic Acid Mimics Caloric Restriction Benefits Through Novel Pathway
Researchers discover how lithocholic acid activates longevity pathways through TULP3 protein, potentially offering caloric restriction benefits without dietary changes.
Summary
Scientists have uncovered the molecular mechanism by which lithocholic acid (LCA), a bile acid that accumulates during caloric restriction, extends lifespan and improves health. The study reveals that LCA binds to TULP3 protein, which then activates sirtuins to modify v-ATPase and ultimately trigger AMPK—a master metabolic regulator. This pathway mimics caloric restriction benefits including muscle rejuvenation and extended lifespan in multiple species, offering potential therapeutic targets for healthy aging.
Detailed Summary
This groundbreaking Nature study reveals the complete molecular pathway through which lithocholic acid (LCA) reproduces the anti-aging benefits of caloric restriction. LCA is a bile acid that naturally accumulates in mammals during periods of reduced food intake, and previous research showed it could activate AMPK and extend lifespan, but the mechanism remained unclear.
The researchers discovered that LCA works through a sophisticated four-step pathway. First, LCA binds to TULP3 (TUB-like protein 3), which was identified as the LCA receptor through proteomics analysis. Second, the LCA-TULP3 complex allosterically activates sirtuin proteins, particularly SIRT1. Third, activated sirtuins deacetylate specific lysine residues (K52, K99, K191) on the V1E1 subunit of v-ATPase, the cellular proton pump. Finally, this deacetylation inhibits v-ATPase, triggering the lysosomal glucose-sensing pathway that activates AMPK.
The functional significance was demonstrated across multiple species. In aged mice, muscle-specific expression of a deacetylation-mimicking V1E1 mutant (3KR) strongly activated AMPK and rejuvenated muscle tissue. In nematodes and fruit flies, LCA extended both lifespan and healthspan through homologous proteins (tub-1 and ktub respectively), confirming evolutionary conservation of this pathway.
The study provides compelling evidence that this TULP3-sirtuin-v-ATPase-AMPK axis represents a fundamental longevity mechanism. The researchers showed that LCA activates AMPK independently of traditional energy stress signals (AMP/ATP ratios) or calcium levels, instead working through the lysosomal pathway. This discovery offers potential therapeutic targets for achieving caloric restriction benefits without actual dietary restriction, which could have significant implications for healthy aging interventions.
Key Findings
- LCA binds TULP3 protein to activate sirtuins and trigger anti-aging pathways
- Sirtuins deacetylate v-ATPase at specific lysine residues to activate AMPK
- V1E1 deacetylation mutant rejuvenates aged muscle tissue in mice
- LCA extends lifespan in worms and flies through conserved protein homologs
- Pathway mimics caloric restriction benefits without dietary changes
Methodology
Researchers used proteomics to identify TULP3 as LCA receptor, performed extensive mutagenesis studies on v-ATPase subunits, and validated findings across mouse, nematode, and fruit fly models using genetic knockouts and tissue-specific expression systems.
Study Limitations
Study focuses primarily on laboratory models; human relevance requires validation. Long-term safety of LCA supplementation or pathway manipulation needs assessment. Optimal dosing and delivery methods for therapeutic applications remain to be determined.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.